反应性空气等离子处理增强了小麦脂质的提取产量和生物活性抗衰老特性
Hyun-Joo Kim1, Narae Han2, Jin Hee Bae3
1Department of Food Science, National Institute of Crop and Food Science, Rural Development Administration, Suwon, 16613, Republic of Korea. tlrtod@korea.kr.
Scientific reports
|December 29, 2025
概括
反应性空气等离子体 (ReAP) 治疗显著增强小麦脂质提取,并增强抗衰老特性. 这种方法通过增加有益的脂肪酸和增强皮肤活性来提高化品潜力.
科学领域:
- 农业科学 农业科学
- 生物技术是生物技术.
- 化品科学 化品科学
背景情况:
- 有限的研究存在于反应性空气等离子体 (ReAP) 的小麦脂质增强.
- 小麦脂质显示出化品应用的潜力,但提取和生物活性需要优化.
研究的目的:
- 研究ReAP处理对小麦脂质提取产量的影响.
- 评估ReAP处理的小麦脂质的抗衰老特性 (弹性酶和铁酶抑制,保湿作用).
- 分析ReAP处理后脂肪酸组成的变化.
主要方法:
- 小麦样本使用表面介电屏障放电 (sDBD) 进行了不同时间 (0,5,10,30分钟) 的处理.
- 使用Folch方法进行了脂质提取.
- 进行了酶抑制测定 (弹性酶,铁酶) 和保湿效果评估.
- 气色谱-质谱 (GC-MS) 分析了脂肪酸概况.
- 微观分析检查了表面结构变化.
主要成果:
- 10分钟的ReAP治疗最大限度地提取了脂质,产量从1.78%增加到2.97%.
- 弹性酶和铁酶抑制活性显著增加,加上增强的保湿效果.
- 棕酸和亚麻酸度分别上升了5.29倍和8.34倍.
- 血处理改变了小麦的表面结构,减少了粗度.
结论:
- 在化品应用中,ReAP治疗有效提高小麦脂质产量和生物活性.
- 用ReAP处理的小麦脂质显示出作为化品成分的显著潜力,这是由于酶抑制和保湿性能的改善.
- 建议进行进一步的体内研究和扩大血系统验证.
更多相关视频
10:26Author Spotlight: Integrating Biochemical Functions of β-Glucanases and Peroxidase Enzymes in Wheat-RWA Interaction
Published on: July 26, 2024
1.1K
07:05Author Spotlight: Eco-Friendly Extraction of Bioactive Compounds Using Polyol-Based Microwave-Assisted Techniques
Published on: August 23, 2024
2.7K
相关概念视频
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
